MoS2–Plasmonic Hybrid Platforms: Next-Generation Tools for Biological Applications

Nanomaterials, Journal Year: 2025, Volume and Issue: 15(2), P. 111 - 111

Published: Jan. 13, 2025

The combination of molybdenum disulfide (MoS2) with plasmonic nanomaterials has opened up new possibilities in biological applications by combining MoS2’s biocompatibility and high surface area the optical sensitivity metals. These MoS2–plasmonic hybrid systems hold great promise areas such as biosensing, bioimaging, phototherapy, where their complementary properties facilitate improved detection, real-time visualization, targeted therapeutic interventions. adjustable features, combined plasmon resonance noble metals gold silver, enhance signal amplification, enabling detailed imaging selective photothermal or photodynamic therapies while minimizing effects on healthy tissue. This review explores various synthesis strategies for hybrids, including seed-mediated growth, situ deposition, heterojunction formation, which enable tailored configurations optimized specific applications. primary focus include highly sensitive biosensors detecting cancer infectious disease biomarkers, high-resolution cellular dynamics, development phototherapy methods that allow accurate tumor ablation through light-induced thermal reactive oxygen species generation. Despite promising advancements translating these platforms into clinical practice requires overcoming considerable challenges, reproducibility, toxicity, stability physiological conditions, delivery, scalable manufacturing. Addressing challenges is essential realizing potential next-generation tools diagnostics therapies.

Language: Английский

---

Coumarin-based fluorescent probe for hypochlorite detection and imaging of acute kidney injury

Sensors and Actuators B Chemical, Journal Year: 2025, Volume and Issue: unknown, P. 137645 - 137645

Published: March 1, 2025

Language: Английский

---

Application of Nanomaterial-Mediated Ferroptosis Regulation in Kidney Disease

International Journal of Nanomedicine, Journal Year: 2025, Volume and Issue: Volume 20, P. 1637 - 1659

Published: Feb. 1, 2025

Abstract: Kidney diseases are a significant global cause of death and disability, resulting from the destruction kidney structure function due to an imbalance between renal parenchymal cells proliferation or recruitment maladaptive cells, caused by various pathogenic factors. Currently, therapies their efficacy for limited. Ferroptosis is newly discovered iron-dependent regulated cell death. The iron homeostasis lipid metabolism affects occurrence progression triggering ferroptosis, which considered important target development disease drugs. However, in clinical practice, targeted ferroptosis therapy faces obstacles such as poor drug solubility, low resistance, imprecise targeting. With rapid nanomaterials medical field, new opportunities have emerged precise regulation treatment diseases. This article provides detailed introduction regulatory mechanisms properties nanomaterials, application diseases, with focus on discussing action therapeutic potential based aim this provide ideas directions future treatments. Keywords: nanomaterial, nanomedicine,

Language: Английский

---

In situ radiochemical doping of functionalized inorganic nanoplatforms for theranostic applications: a paradigm shift in nanooncology

Journal of Nanobiotechnology, Journal Year: 2025, Volume and Issue: 23(1)

Published: June 2, 2025

Language: Английский

---